Carlyle Group sells 4.3% in Indegene for ?636 cr

According to the bulk deal data available on the National Stock Exchange (NSE), CA Dawn Investments, an affiliate of US-based Carlyle, sold 1,02,63,785 shares amounting to a 4.3% stake in Indegene.

Carlyle Group sells 4.3% in Indegene for ?636 cr
Business

Global investment firm Carlyle Group through its arm divested a 4.3% stake in healthcare tech firm Indegene for 636 crore through an open market transaction.

According to the bulk deal data available on the National Stock Exchange (NSE), CA Dawn Investments, an affiliate of US-based Carlyle, sold 1,02,63,785 shares amounting to a 4.3% stake in Indegene.

The shares were offloaded at an average price of 619.82 apiece, taking the transaction value to 636.17 crore.

After the latest transaction, Carlyle's holding in Indegene has come down to 10.22% from 14.52%.

Details of the buyers of Indegene's shares could not be ascertained on the NSE.

Shares of Indegene plunged 6.06% to close at 627 apiece on the NSE.

In two separate deals on the NSE and BSE, financial services company Capital Group on Tuesday trimmed its holding by selling a 2.24% stake in Medi Assist Healthcare Services for nearly 93 crore through open market transactions.

Capital through its arm SmallCap World Fund Inc sold a total of 15.75 lakh shares, or 2.24% stake in Medi Assist Healthcare Services on the NSE and BSE, as per the data.

The shares were disposed of at an average price of 588 apiece on both exchanges, taking the combined deal value to 92.65 crore.

After the stake sale, Capital Group through its arm SmallCap World Fund Inc's shareholding in Medi Assist Healthcare Services has declined to 0.7% from 2.93%. Details of the buyers of Medi Assist Healthcare Services could not be identified on the exchanges.

On Tuesday, shares of Medi Assist Healthcare Services rose 0.18% to close at 588.20 apiece on the BSE, while it settled 0.06% lower at 586.20 per piece on the NSE.